Publications by authors named "John Weil"

Claim this Profile
E
Epidemiology of norovirus disease in the first 2 years of life: A prospective multisite cohort study in Lima, Peru.
Claudio F Lanata, Giselle Soto, Ana I Gil, Joan Neyra, Rubelio Cornejo, John Weil

Int J Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norovirus in children under 2 years of age: an epidemiological study in Panama during the COVID-19 pandemic.
Rodrigo DeAntonio, Morgan Hess-Holtz, Leyda Abrego, Zeuz Capitan-Barrios, Leyla Hernandez Donoso, John Gerard Weil

Front Pediatr· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decrease in norovirus infections in Germany following COVID-19 containment measures.
Ulrich Eigner, Thomas Verstraeten, John Weil

J Infect· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence of medically-attended norovirus gastro-enteritis in Japan: Modelling using a medical care insurance claims database.
Chia-Hsien Chang, Motonobu Sakaguchi, John Weil, Thomas Verstraeten

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Impact of a Focused Deterrence Strategy to Combat Intimate Partner Domestic Violence.
Stacy M Sechrist, John D Weil

Violence Against Women· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling Estimates of Norovirus Disease in Patients with Chronic Medical Conditions.
Thomas Verstraeten, Baoguo Jiang, John G Weil, Jennifer H Lin

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence of childhood and adolescent seizures in the UK from 1999 to 2011: A retrospective cohort study using the Clinical Practice Research Datalink.
Cormac J Sammon, Rachel A Charlton, Julia Snowball, John G Weil

Vaccine· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry.
Susan Sinclair, Marianne Cunnington, John Messenheimer, John Weil, Janet Cragan

Pharmacoepidemiol Drug Saf· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project.
Victoria Abbing-Karahagopian, Xavier Kurz, Frank de Vries, Tjeerd P van Staa, Yolanda Alvarez, John G Weil

Curr Clin Pharmacol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the adjuvant solely to blame?
Theodore Tsai, Giuseppe Del Giudice, Antonio Crucitti, John Weil, Vas Narasimhan

BMJ· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study.
Terho Heikkinen, James Young, Erik van Beek, Henk Franke, Thomas Verstraeten, John G Weil

Am J Obstet Gynecol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of new-onset seizures in mild to moderate Alzheimer disease.
Michael C Irizarry, Shelia Jin, Feng He, Jennifer A Emond, Rema Raman, John G Weil

Arch Neurol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.
Rachel A Charlton, John G Weil, Marianne C Cunnington, Sayantani Ray, Corinne S de Vries

Drug Saf· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Background incidence of serum creatinine threshold rises in a predominantly female clinical trial population without underlying renal disease.
Yanfang Liu, Christine Hunt, Chanchal Bains, John G Weil

Regul Toxicol Pharmacol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying major congenital malformations in the UK General Practice Research Database (GPRD): a study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD.
Rachel A Charlton, John G Weil, Marianne C Cunnington, Corinne S de Vries

Drug Saf· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring differential prescribing between anti-epileptic drugs in epilepsy patients with a history of mood disorders.
Lianna Ishihara, David J Webb, Michael Irizarry, John Weil

Pharmacoepidemiol Drug Saf· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regarding the need, or lack thereof, of a comparator group for pregnancy registries.
Rachel Charlton, Marianne Cunnington, John Weil, Corinne de Vries

Birth Defects Res A Clin Mol Teratol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of placebo response in pooled lamotrigine neuropathic pain clinical trials.
Michael C Irizarry, David J Webb, Zahid Ali, Boris A Chizh, Michael Gold, John G Weil

Clin J Pain· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance in systems with equivalent spin-1/2 nuclides. Part 3: Ket analysis and spectral intensities.
John A Weil, David F Howarth

J Magn Reson· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Background incidence of liver chemistry abnormalities in a clinical trial population without underlying liver disease.
John G Weil, Chanchal Bains, Adam Linke, Douglas W Clark, Heide A Stirnadel

Regul Toxicol Pharmacol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance in systems with equivalent spin-1/2 nuclides. Part 2: energy values and spin states.
Sergiy M Nokhrin, David F Howarth, John A Weil

J Magn Reson· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease.
Michael C Irizarry, David J Webb, Chanchal Bains, Steven J Barrett, Robert Y Lai, John G Weil

J Alzheimers Dis· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis.
Marianne Cunnington, David Webb, Nawab Qizilbash, David Blum, Adrian Mander, John Weil

Pharmacoepidemiol Drug Saf· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries.
Rachel A Charlton, Marianne C Cunnington, Corinne S de Vries, John G Weil

Drug Saf· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis